JILL TOLIVER: Open Payments
NPI 1518923499 · WOODBURY, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$66,422 in 122 payments from 7 companies in 2025. Trend: 2023 $15,151 · 2024 $19,817 · 2025 $66,422
Speaker / faculty: $42,855Consulting: $13,367Travel & lodging: $8,565Food & beverage: $1,635
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 59 | $44,394 |
| Alkermes, Inc. | 24 | $9,789 |
| E.R. Squibb & Sons, L.L.C. | 19 | $6,637 |
| Otsuka America Pharmaceutical, Inc. | 17 | $5,558 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Sage Therapeutics, LLC | 1 | $14 |
Products named: INGREZZA, LYBALVI, REXULTI, COBENFY, ARISTADA, TRINTELLIX, Auvelity, ZURZUVAE.
Industry payments across MN — which companies pay providers there.
